Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMPEDIMED LIMITED Capital/Financing Update 2021

Oct 24, 2021

65135_rns_2021-10-24_3688505d-bb00-4374-8c65-82a0a5ca2be0.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Market Announcement

==> picture [33 x 50] intentionally omitted <==

25 October 2021

==> picture [451 x 5] intentionally omitted <==

Impedimed Limited (ASX: IPD) – Trading Halt

Description

The securities of Impedimed Limited (‘IPD’) will be placed in trading halt at the request of IPD, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 27 October 2021 or when the announcement is released to the market.

Issued by

Alice Montefiore-King

Adviser, Listings Compliance (Sydney)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

25 October 2021 ASX Limited

==> picture [215 x 69] intentionally omitted <==

25 October 2021

Ms Alice Montefiore-King Advisor, Listings Compliance ASX Compliance Pty Ltd 20 Bridge Street Sydney NSW 2000

Dear Ms Montefiore-King,

Pursuant to ASX Listing Rule 17.1, ImpediMed Limited (ASX: IPD) ( ImpediMed ) requests an immediate trading halt be granted by ASX Limited with respect to its shares, to apply from the commencement of trading on Monday, 25 October 2021 .

The trading halt is requested in connection with a proposed capital raising.

The following information is provided in accordance with Listing Rule 17.1:

  1. Reason for trading halt – to avoid trading taking place on an uninformed basis and to allow the proposed capital raising to take place in an orderly manner.

  2. Duration of the trading halt – ImpediMed requests that the trading halt remain in place until the earlier of ImpediMed making an announcement to ASX concerning the outcome of the proposed capital raising and the commencement of trading on Wednesday, 27 October 2021.

  3. No reason – ImpediMed is not aware of any reason why the trading halt should not be granted.

  4. Further information – none.

Should you have any questions, please do not hesitate to contact me on +61 414 731 082.

Yours sincerely, Leanne Ralph Company Secretary

ImpediMed Ltd ● ABN 65 089 705 144 ● TEL: +61 (0)7 3860 3700 FAX: 61 (0)7 3260 1225 ● FREE CALL: 1800 638 477 ● EMAIL: [email protected]